IBC’s 22nd International Antibody Development & Production Conference To Anchor Biopharmaceutical Development & Production Week — March 2-6, 2009

February 5, 2009 at 8:00 am Leave a comment


IBC is pleased to hold its 22nd International Antibody Development & Production Conference in Carlsbad, California on March 4-6, 2009.




Antibody Development & Production is the anchor conference for IBC’s Biopharmaceutical Development & Production Week which includes five conferences focused on these specific biopharmaceutical disciplines: antibody development and production, process validation, technology transfer, outsourcing manufacturing and non-antibody protein therapeutics.




The Antibody Development & Production conference provides the latest scientific and technical approaches to accelerating the development of robust processes across the spectrum of upstream and downstream processing.




Antibody Development & Production features three keynote presentations:




— How do We Get to 30g/L Using Fed-Batch Technology? What are the
Limitations?


Thomas Ryll, Ph.D., Director of Cell Culture Development, Biogen Idec




— Thoughts from the New Kids on the Biotherapeutics Block
Rick Rutter, Ph.D., Vice President, Pharmaceutical Sciences, Biologics,
Pfizer, Inc.




— Next Generation Commercial Processes


Timothy S. Charlebois, Ph.D., Director, Cell & Molecular Sciences, Wyeth
BioPharma



In addition, IBC has expanded this program to include strategy discussion forums, interactive workshops and panel discussions that will provide valuable and uncensored insight on today’s most critical topics, including:




— Genomics, Proteomics and Metabalomics: Applications to Antibody
Production


— Protein A Capture – Perception and Reality


— Alternative Purification Methods – Promise or Over-Promise?


— Future of Continuous Downstream Processing


— Can Downstream Processing Keep Pace Economically with Cell Culture?


— Chemically Defined vs. Non-Defined Additives


— Hydrolysates and Lot-to-Lot Variability



This week-long event provides biopharmaceutical professionals the opportunity to network face-to-face with 700 industry peers and is comprised of over 120 presentations that include exclusive case studies, interactive workshop sessions, industry panels, and strategic discussion groups.




Attendees may choose to attend one conference or attend for the week with the dual conference pass. This event also includes an exhibit hall, open to attendees. Complete details on these events can be found at http://www.IBCLifeSciences.com/bdpweek.



IBC Life Sciences is the worldwide leader in scientific, technological and business conferences and courses for the life science industry. For more information, visit http://www.IBCLifeSciences.com.



IBC Life Sciences

[Via http://www.medicalnewstoday.com]

Advertisements

Entry filed under: Uncategorized.

Healthy Kidney Removed Through Donor’s Vagina Alzheimer Europe Welcomes Launch Of English Dementia Strategy

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Trackback this post  |  Subscribe to the comments via RSS Feed


Archives

Top Clicks

  • None

Blog Stats

  • 15,525 hits

%d bloggers like this: